Observational studyClinical transplantation2024

Evaluating Real-World Experience With Maribavir for Treatment of Refractory/Resistant Cytomegalovirus in Renal Transplant Recipients.

Vivek B Beechar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.